Aaron Richard Mccabe
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$10.3MFederal grants as PI16 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
16 awards · $10.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2021 | NIH | SBIR Phase II Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter | $395K | — |
| Sep 1, 2020 | NIH | SBIR Phase II Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter | $1.5M | — |
| Jul 10, 2020 | NIH | STTR Phase II Validation of Novel Therapeutic Approach for Leptomeningeal Metastases | $637K | — |
| May 8, 2020 | NIH | STTR Phase II Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis | $939K | — |
| Jul 24, 2019 | NIH | STTR Phase II Validation of Novel Therapeutic Approach for Leptomeningeal Metastases | $646K | — |
| Jul 17, 2019 | NIH | SBIR Phase II Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter | $561K | — |
| May 24, 2019 | NIH | STTR Phase II Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis | $970K | — |
| Jul 9, 2018 | NIH | STTR Phase II Validation of Novel Therapeutic Approach for Leptomeningeal Metastases | $666K | — |
| May 31, 2018 | NIH | STTR Phase II Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis | $999K | — |
| Dec 14, 2017 | NIH | STTR Phase II Validation of Novel Therapeutic Approach for Cryptococcal Meningitis | $487K | — |
| Dec 29, 2016 | NIH | STTR Phase II Validation of Novel Therapeutic Approach for Cryptococcal Meningitis | $1.0M | — |
| Sep 13, 2016 | NIH | SBIR Phase II Transcutaneous Energy Transmission System for Fully Implantable VADs | $98K | — |
| Aug 17, 2016 | NIH | STTR Phase I Directed Chemotherapy Delivery for Leptomeningeal Metastases | $225K | — |
| Jul 17, 2015 | NIH | STTR Phase I Directed Antifungal Therapy for HIV-associated Cryptococcal Meningitis | $225K | — |
| Jul 17, 2015 | NIH | STTR Phase I Development of a Novel Therapeutic Approach for Cryptococcal Meningitis | $225K | — |
| Apr 23, 2015 | NIH | SBIR Phase II Transcutaneous Energy Transmission System for Fully Implantable VADs | $721K | — |
Peer ranks
Federal funding#16
Awards as PI#20
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.